XML 101 R87.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Reporting - Revenues and Operating Income by Reportable Segment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting Information [Line Items]      
Revenues $ 2,225.1 $ 1,860.1 $ 1,831.4
Adjusted EBITDA 339.6 256.6 258.6
Reconciliation of Adjusted EBITDA:      
Income (loss) before income taxes 81.2 (18.8) 54.6
Less: Net income attributable to non-controlling interests (141.6) (117.4) (119.9)
Depreciation and amortization 98.8 94.8 76.5
Interest expense, net 221.0 201.8 178.9
Equity-based compensation expense 17.4 13.2 10.2
Transaction, integration and acquisition costs 46.1 38.2 36.1
Loss (gain) on disposals, net 2.2 5.7 (4.4)
Litigation settlements and other litigation costs 5.6 6.4 4.6
Impairment charges 0.0 33.5 7.9
Gain on escrow release 0.0 (0.8) 0.0
Loss on debt extinguishment 9.1 0.0 11.7
Hurricane-related impacts (0.2) 0.0 0.0
Tax receivable agreement expense 0.0 0.0 2.4
Transaction and integration costs 39.8 23.2 19.0
Start-up costs related to de novo surgical hospital 6.3 15.0 17.1
Litigation settlement 0.0 1.2 0.2
Other litigation costs 5.6 5.2 4.4
All other      
Segment Reporting Information [Line Items]      
Adjusted EBITDA (84.1) (80.7) (74.3)
Surgical Facility Services | Operating Segments      
Segment Reporting Information [Line Items]      
Revenues 2,157.8 1,793.4 1,748.2
Adjusted EBITDA 422.0 339.3 328.9
Ancillary Services | Operating Segments      
Segment Reporting Information [Line Items]      
Revenues 67.3 63.6 79.4
Adjusted EBITDA 1.7 (3.4) 2.6
Optical Services | Operating Segments      
Segment Reporting Information [Line Items]      
Revenues 0.0 3.1 3.8
Adjusted EBITDA $ 0.0 $ 1.4 $ 1.4